Abiopharma

Clinical trial NCT07596485 updates: 1. start date: 2026-06-01 → 2026-08-01 2. completion date: 2028-12-01 → 2029-02-01 3. primary completion date: 2028-12-01 → 2029-02-01

Clinical trial NCT06619236: enrollment: 448 → 530 participants.

Clinical trial NCT06697184 updates: 1. status: ACTIVE_NOT_RECRUITING → RECRUITING 2. completion date: 2027-12-31 → 2032-11-30 3. primary completion date: 2027-06-01 → 2029-11-30 4. enrollment: 56 → 258 participants

Clinical trial NCT06714006 updates: 1. completion date: 2027-03-01 → 2028-11-01 2. primary completion date: 2026-09-01 → 2028-11-01 3. enrollment: 116 → 166 participants

Clinical trial NCT06920459 updates: 1. completion date: 2036-12-31 → 2037-06-01 2. primary completion date: 2028-12-31 → 2029-06-01 3. enrollment: 40 → 50 participants

Clinical trial NCT06814145: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT05976243: primary completion date: 2026-05-22 → 2026-05-11.

Clinical trial NCT05910450 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-01 → 2026-01-26

Clinical trial NCT06979726 updates: 1. completion date: 2026-05-01 → 2026-12-31 2. primary completion date: 2026-03-31 → 2026-11-30

Clinical trial NCT05613894 updates: 1. status: RECRUITING → SUSPENDED 2. completion date: 2028-05-01 → 2028-12-01 3. primary completion date: 2026-05-01 → 2026-12-01